New Treatises
- This annual publication provides a comprehensive overview of U.S. employment law, highlighting significant case law, legislative changes, government agency actions, and other developments of the prior year. Major topics include wage-and-hour laws and litigation; the Office of Federal Contract Compliance Programs (OFCCP) and related recent developments, compliance initiatives, case law, and settlements; discrimination based on […]
- This annual publication provides a comprehensive overview of U.S. employment law, highlighting significant case law, legislative changes, government agency actions, and other developments of the prior year. Major topics include wage-and-hour laws and litigation; the Office of Federal Contract Compliance Programs (OFCCP) and related recent developments, compliance initiatives, case law, and settlements; discrimination based on […]
- Comprehensive overview of the previous year’s most important developments in employment law. Includes current wage-and-hour issues, discrimination, ADA, privacy, whistleblowing, FMLA, privacy, social media, and more.
- Comprehensive overview of the previous year’s most important developments in employment law. Includes current wage-and-hour issues, discrimination, ADA, privacy, whistleblowing, FMLA, privacy, social media, and more.
- Comprehensive overview of the previous year’s most important developments in employment law. Includes current wage-and-hour issues, discrimination, ADA, privacy, whistleblowing, FMLA, privacy, social media, and more.
New Answer Books
- The Eleventh Edition has been extensively updated with significant developments across key areas of pharmaceutical regulation, including a new chapter on the FDA’s shift towards greater transparency and its impact on product liability exposure, updated insights on evolving evidence standards for drug approvals, and the latest best practices for navigating FDA inspections and remote regulatory […]
- Q&A guide to the laws governing the pharmaceutical industry. Coverage of FDA regulation and enforcement, regulation of advertising and promotional activity, REMS, product liability, pharmaceutical price reporting, the FDCA, 21st Century Cures Act, and much more.
- The Eleventh Edition has been extensively updated with significant developments across key areas of pharmaceutical regulation, including a new chapter on the FDA’s shift towards greater transparency and its impact on product liability exposure, updated insights on evolving evidence standards for drug approvals, and the latest best practices for navigating FDA inspections and remote regulatory […]
- Covers online privacy policies, the Children’s Online Privacy and Protection Act, mobile device privacy, financial privacy, medical privacy, workplace privacy, online behavioral advertising and tracking, and privacy enforcement and litigation. Includes a chapter on global privacy laws.
- Covers online privacy policies, the Children’s Online Privacy and Protection Act, mobile device privacy, financial privacy, medical privacy, workplace privacy, online behavioral advertising and tracking, and privacy enforcement and litigation. Includes a chapter on global privacy laws.
New Course Handbooks
- Delaware law continues to play a critical role in U.S. corporate and securities law, particularly in today’s challenging and changing business environment. This unique program focuses on the important Delaware corporate law developments as shaped by the courts and legislature over the past year and how they impact your corporate or legal practice. Our expert […]
- Delaware law continues to play a critical role in U.S. corporate and securities law, particularly in today’s challenging and changing business environment. This unique program focuses on the important Delaware corporate law developments as shaped by the courts and legislature over the past year and how they impact your corporate or legal practice. Our expert […]
- As autonomous technology moves from testing to commercial deployment, the legal landscape is shifting rapidly. This transition presents a "dizzying array" of possibilities but creates tension between federal and state authority, novel liability theories, and complex contracting requirements. You should attend to gain practical guidance on navigating the regulatory patchwork (NHTSA, FMCSA, OSHA, state privacy, […]
- The Foreign Corrupt Practices Act (“FCPA”) is at the top of most NY companies’ key risk areas, but the enforcement environment is uncertain given recent federal announcements. Nevertheless, other countries and international organizations continue to ramp up their anti-corruption enforcement, and effective anti-corruption programs continue to be hallmarks of good governance. This program, taught by […]
- The Foreign Corrupt Practices Act (“FCPA”) is at the top of most NY companies’ key risk areas, but the enforcement environment is uncertain given recent federal announcements. Nevertheless, other countries and international organizations continue to ramp up their anti-corruption enforcement, and effective anti-corruption programs continue to be hallmarks of good governance. This program, taught by […]